Use code SIMOA26 to receive 15% off all Simoa services through February 2027.
Use code SIMOA26 to receive 15% off all Simoa services through February 2027.

When ultrasensitivity is critical to your experiment’s success, RayBiotech’s experienced service team can use the Simoa® (single molecule array) protein detection platform to help you find that needle in a haystack.
With our Simoa assay service, we can achieve orders of magnitude more sensitivity than standard sandwich-based immunoassay techniques, detecting as little as femtogram (fg/mL) concentrations, while consuming as little as a few microliters of sample. This ultrasensitive detection capability enables the detection and quantification of biomarkers at concentrations that have previously been difficult or impossible to measure.
Ready to send your samples? Please complete the SIMOA Sample Service Form and review the Sample Shipment Instructions.
Already have a Simoa instrument? RayBiotech provides affordable, Simoa-validated antibody pairs for your in-lab use. Browse our antibody pairs.
If you need multi-analyte detection, RayBiotech can multiplex up to 4 analytes per test, without requiring any additional sample. In addition to our popular neurological panel (Aβ40, Aβ42, GFAP, NfL), we also provide panel customization to your specifications.
If you don’t see your target in the list of assays below, we can convert any of our validated ELISA antibody pairs into the ultrasensitive Simoa assay format. Browse our ELISA target list. If you prefer to run your own assay, browse our antibody pairs, including a complete list of ready-to-use Simoa antibody pair kits.
Founded in 2001 as the first company to commercialize the antibody array, we continue to use our decades of experience in multiplex, high-throughput protein analysis to deliver outstanding protein detection and analysis services to the research community.
See how researchers used our Simoa service, from Alzheimer’s patient plasma to mouse tumor tissue.
FEATURED STUDY · ALZHEIMER’S DISEASE
Two 2026 real-world studies followed Japanese Alzheimer’s disease patients receiving lecanemab, examining ATNIVS biomarker heterogeneity and amyloid-related imaging abnormalities (ARIA). RayBiotech measured plasma NfL and GFAP from the study biobank on the Simoa HD-X using the Neurology 2-Plex B assay.
“...Simoa HD-X platform and the Neurology 2-Plex B multiplex assay ... at Raybiotech, Inc.”
From the methods section, J Prev Alzheimers Dis, 2026
Sample | Human plasma |
Assay | Neurology 2-Plex B (N2PB) |
Analytes | NfL, GFAP |
Cohort | Real-world lecanemab patients |
Two papers from this cohort:
ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab
Simoa is an ultrasensitive ELISA that uses antibody-coated beads, a fluorescently conjugated detection antibody, and digital readout. After the beads, sample, and detection antibody have been mixed together, the solution is applied to a cartridge with over 235,000 microwells. Each microwell can hold only one bead. Oil is then added to the cartridge, which pushes the sample across the surface of the microwell array and forms a liquid-tight seal of the wells.
The fluorescence of each well is measured using a fully or semi-automated system equipped with a fluorescent microscope. The instrument is manufactured by the developer of Simoa(Quanterix; Billerica, MA; USA). Quantitation of target protein concentration is based on the number of microwells with fluorescent signal and not the intensity of the fluorescent signal, making the readout a "digital" one. Since each well can contain only one bead, the number of microwells with fluorescence is proportional to the amount of target protein in the sample. This approach enables quantitative, ultrasensitive single molecule detection.

Check out our list of available analytes. Multiplexing is also available for up to 4 analytes.
Don’t see the target you’re looking for? We have a library of thousands of ELISA antibodies which can be converted to the ultrasensitive Simoa assay format. Browse our target list here. Then fill out our Request a Quote form with the target you’re interested in and we will contact you with a quote. Please note: the conversion requires an additional 4-6 week lead time.
To get started, fill out our Request a Quote form with the targets you’re interested in. We’ll get back to you as soon as possible.
Still have questions?
Maximize operational efficiency while receiving data you can depend on when you trust your ELISA service needs to the experienced scientists at RayBiotech.
From custom protein or peptide array printing to complete quantitative and/or discovery studies, we can help you advance your multiplex protein analysis projects efficiently and with confidence.
Whether you’re short on analytical resources or expertise, our experienced team can support your studies with a wide range of biostatistics and bioinformatics services.
Your cart is empty.
Target | LLOD | LLOQ | ELISA Kit |
|---|---|---|---|
Alpha-syn (Total) | 2.47 pg/ml | 8.7 pg/ml | |
B7-H1 (CD274 / PD-L1) | 0.055 pg/ml | 0.617 pg/ml | |
BDNF | 0.0042 pg/ml | 0.0293 pg/ml | |
C-Peptide (Proinsulin) | 0.013 pg/ml | 0.021 pg/ml | |
FCRL5 (FcRH5) | 0.00651 pg/ml | 0.0409 pg/ml | |
GFAP | 0.138 pg/ml | 0.635 pg/ml | |
GM-CSF (CSF2) | 0.0019 pg/ml | 0.0103 pg/ml | |
HIV p24 | 0.0027 pg/ml | 0.01 pg/ml | |
IFN-alpha (IFNA1) | 0.003 pg/ml | 0.016 pg/ml | |
IFN-alpha Multi Subtype | 0.002 pg/ml | 0.018 pg/ml | |
IFN-gamma (IFNG) | 0.015 pg/ml | 0.098 pg/ml | |
IL-1 beta (IL-1F2 / IL1B) | 0.002 pg/ml | 0.008 pg/ml | |
IL-1 beta (IL-1F2 / IL1B) 3.0 | 0.002 pg/ml | 0.016 pg/ml | |
IL-10 (IL10) | 0.015 pg/ml | 0.048 pg/ml | |
IL-11 (IL11) | 0.015 pg/ml | 0.048 pg/ml | |
IL-12 p70 (IL12A) | 0.003 pg/ml | 0.011 pg/ml | |
IL-15 (IL15) | 0.003 pg/ml | 0.0062 pg/ml | |
IL-17 (IL17A) | 0.00144 pg/ml | 0.00625 pg/ml | |
IL-17A (IL17A) | 0.002 pg/ml | 0.012 pg/ml | |
IL-22 (IL22) | 0.008 pg/ml | 0.061 pg/ml | |
IL-23 (IL23A/B) | 0.00456 pg/ml | 0.0105 pg/ml | |
IL-28A (IFN lambda 2 / IL28A) | 0.0108 pg/ml | 0.056 pg/ml | |
IL-31 (IL31) | 0.00153 pg/ml | 0.00811 pg/ml | |
IL-4 (IL4) | 0.0046 pg/ml | 0.039 pg/ml | |
IL-5 (IL5) | 0.002 pg/ml | 0.01 pg/ml | |
IL-6 (IL6) | 0.01 pg/ml | 0.028 pg/ml | |
IL-7 (IL7) | 0.009 pg/ml | 0.103 pg/ml | |
IP-10 (CXCL10) | 0.052 pg/ml | 0.177 pg/ml | |
Kallikrein 6 (KLK6) | 0.812 pg/ml | 1.1 pg/ml | |
MAPT (Tau) | 0.019 pg/ml | 0.061 pg/ml | |
NfL (NEFL) | 0.062 pg/ml | 1.24 pg/ml | |
PKC gamma (PRKCG) | 0.201 pg/ml | 0.828 pg/ml | |
PLGF (PGF PGFL PLGF) | 0.064 pg/ml | 0.3 pg/ml | |
PSD95 | 0.173 pg/ml | 0.823 pg/ml | |
SARS-CoV-2 N Protein Antigen | 0.099 pg/ml | 0.313 pg/ml | |
SARS-CoV-2 N Protein Antigen | 0.0187 pg/ml | 0.0798 pg/ml | |
SARS-CoV-2 Spike IgG | 15 pg/ml | 8200 pg/ml | |
SNAP-25 | 1.47 pg/ml | 2.56 pg/ml | |
sTREM-2 (TREM2) | 0.9 pg/ml | 66 pg/ml | |
Tau:Brain Derived (BD-Tau) | 0.044 pg/ml | 0.133 pg/ml | |
Tau: p-Tau 181 | 0.724 pg/ml | 7.27 pg/ml | |
Tau: p-Tau 205 | 0.047 pg/ml | 0.225 pg/ml | |
Tau: p-Tau 217 | 0.001 pg/ml | 0.01 pg/ml | |
Tau: p-Tau 217 ALZPath | 0.0008 pg/ml | 0.00326 pg/ml | |
Tau: p-Tau 231 | 0.232 pg/ml | 1.23 pg/ml | |
TDP-43 (TARDBP) | 2.48 pg/ml | 8.23 pg/ml | |
TGF beta | 0.137 pg/ml | 0.514 pg/ml | |
TNF alpha (TNFA) | 0.016 pg/ml | 0.034 pg/ml | |
VEGI (TL1A / TNFSF15) | 3.22 pg/ml | 18.5 pg/ml | |
YKL-40 (CHI3L1) | 0.349 pg/ml | 1.46 pg/ml |
Target | LLOD | LLOQ | ELISA Kit |
|---|---|---|---|
IL-1 beta (IL-1F2 / IL1B) | 0.518 pg/ml | 2.26 pg/ml | |
NfL (NEFL) | 0.085 pg/ml | 0.539 pg/ml |
Human multiplex panels, up to 4 analytes per test.
Assay | Target | LLOD | LLOQ |
|---|---|---|---|
Cytokine 4-Plex A(C4PA) | IL-1 beta (IL-1F2 / IL1B) | 0.002 pg/mL | 0.01 pg/mL |
IL-6 (IL6) | 0.008 pg/mL | 0.028 pg/mL | |
IL-10 (IL10) | 0.033 pg/mL | 0.143 pg/mL | |
TNF alpha (TNFA) | 0.061 pg/mL | 0.481 pg/mL | |
Cytokine 4-Plex B(C4PB) | IL-4 (IL4) | 0.003 pg/mL | 0.01 pg/mL |
IL-5 (IL5) | 0.004 pg/mL | 0.01 pg/mL | |
IL-13 (IL13) | 0.004 pg/mL | 0.034 pg/mL | |
IL-17A (IL17A) | 0.002 pg/mL | 0.008 pg/mL | |
Cytokine 4-Plex C(C4PC) | IL-2 (IL2) | 0.005 pg/mL | 0.019 pg/mL |
IL-6 (IL6) | 0.008 pg/mL | 0.031 pg/mL | |
IL-8 (IL8 / CXCL8) | 0.014 pg/mL | 0.07 pg/mL | |
IFN-gamma (IFNG) | 0.012 pg/mL | 0.075 pg/mL | |
Neurology 2-Plex B(N2PB) Published | NfL (NEFL) | 0.08 pg/mL | 0.402 pg/mL |
GFAP | 0.111 pg/mL | 0.635 pg/mL | |
Neurology 4-Plex E(N4PE) | beta Amyloid 40 (Aβ40) | 0.133 pg/mL | 0.353 pg/mL |
beta Amyloid 42 (Aβ42) | 0.13 pg/mL | 0.239 pg/mL | |
GFAP | 0.139 pg/mL | 0.402 pg/mL | |
NfL (NEFL) | 0.072 pg/mL | 0.635 pg/mL | |
Neurology 4-Plex D(N4PD) | GFAP | 0.121 pg/mL | 0.805 pg/mL |
NfL (NEFL) | 0.094 pg/mL | 0.36 pg/mL | |
BD-Tau | 0.029 pg/mL | 0.259 pg/mL | |
UCH-L1 | 0.577 pg/mL | 3.48 pg/mL |